|
 |
2/7/2012
|
|
|
Cancer News on the Net® is dedicated to bringing patients and their
families the latest news and information on cancer diagnosis, treatment and
prevention. This service is offered for free as our gift to you. Hopefully,
you will find it helpful. The only thing we ask is that you let us know how
we can improve! Please read this disclaimer before entering the site.
|
| |
|
|
Lung Cancer: Radiofrequency Ablation (RFA) of Lung Tumors
RFA is a promising local therapy that has evolved rapidly in recent years for the treatment of primary and secondary cancers in the lung. The feasibility and safety profile in humans are well established. Complications following RFA are similar to those of CT-guided lung biopsies. However, sufficient long term results beyond 5 years are not yet available due to the relatively short time that this technology has been in use. Patients with smaller tumors (less than or equal to 3 cm) and fewer tumor nodules (less than or equal to 5 lesions) who are considered poor surgical candidates or who develop residual or recurrent disease despite maximal conventional therapy, and have tumors that are away from vital structures are the best candidates for RFA. Hence, RFA can be safely offered to patients who cannot undergo surgical resection. However the role of RFA in patients who are candidates for surgical resection is unproven, and there is no evidence on whether RFA is more or less effective that focused radiation (sterotactic body radiation therapy). Overall, RFA is a highly promising modality that may be used to our patients' advantage either as a solitary treatment or in combination with conventional therapy. [more]
|
| |
PROSTATE CANCER: URINE TEST CAN PREDICT HIGH-RISK PROSTATE CANCER IN MEN WHO CHOOSE WATCHFUL WAITING
Initial results of a multicenter study indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening [more]
Multiple Myeloma Treatment: Experimental drug combination ‘encouraging’ in relapsed multiple myeloma
SAN DIEGO–When the targeted drug bortezomib stops working in patients with advanced multiple myeloma, the patients survive only an average of five months longer. [more]
Chronic Lymphocytic Leukemia Research - Results of DNA study offers clues for future treatments
SAN DIEGO—The most comprehensive search to date of DNA abnormalities in chronic lymphocytic leukemia (CLL) has unearthed several new altered genes that drive this common blood cancer, a finding that [more]
|
|
|
|
|
|
|
|
|
|
|
|
|
Team5 Corporation located in Manhattan (New York) is a Web Development company specializing in
large scale database driven web sites.
{www.team5.com}
|
|
|
|
|
Search for great prices on apparel, electronics, sporting goods and more.
Buy online and save.
{www.shoppingnews.com}
|
|
|
|
 |
|
|
|
 |
